Registro:

Referencias:

• Gruner, J.A., Marcy, V.R., Lin, Y.G., Bozyczko-Coyne, D., Marino, M.J., The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents (2009) Sleep, 32, pp. 1425-1438
• Krasnova, I.N., Cadet, J.L., Methamphetamine toxicity and messengers of death (2009) Brain Res Rev, 60, pp. 379-407
• Deng, X., Ladenheim, B., Jayanthi, S., Cadet, J.L., Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb (2007) Biological Psychiatry, 61, pp. 1235-1243
• Bowyer, J.F., Robinson, B., Ali, S., Schmued, L.C., Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure (2008) Synapse, 62, pp. 193-204
• Deng, X., Ladenheim, B., Tsao, L.I., Cadet, J.L., Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity (1999) Journal of Neuroscience, 19, pp. 10107-10115
• O'Callaghan, J.P., Miller, D.B., Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse (1994) The Journal of Pharmacology and Experimental Therapeutics, 270, pp. 741-751
• Ricaurte, G.A., Guillery, R.W., Seiden, L.S., Schuster, C.R., Moore, R.Y., Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain (1982) Brain Research, 235, pp. 93-103
• Deng, X., Wang, Y., Chou, J., Cadet, J.L., Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method (2001) Brain Res Mol Brain Res, 93, pp. 64-69
• Zhu, J.P., Xu, W., Angulo, J.A., Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice (2006) Neuroscience, 140, pp. 607-622
• Jayanthi, S., Deng, X., Bordelon, M., McCoy, M.T., Cadet, J.L., Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex (2001) FASEB J, 15, pp. 1745-1752
• Bowyer, J.F., Davies, D.L., Schmued, L., Broening, H.W., Newport, G.D., Further studies of the role of hyperthermia in methamphetamine neurotoxicity (1994) Journal of Pharmacology and Experimental Therapeutics, 268, pp. 1571-1580
• Thomas, D.M., Walker, P.D., Benjamins, J.A., Geddes, T.J., Kuhn, D.M., Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation (2004) J Pharmacol Exp Ther, 311, pp. 1-7
• Thomas, D.M., Kuhn, D.M., Cyclooxygenase-2 is an obligatory factor in methamphetamine-induced neurotoxicity (2005) J Pharmacol Exp Ther, 313, pp. 870-876
• Sekine, Y., Ouchi, Y., Sugihara, G., Takei, N., Yoshikawa, E., Methamphetamine causes microglial activation in the brains of human abusers (2008) Journal of Neuroscience, 28, pp. 5756-5761
• Ballon, J.S., Feifel, D., A systematic review of modafinil: Potential clinical uses and mechanisms of action (2006) J Clin Psychiatry, 67, pp. 554-566
• Garcia-Rill, E., Heister, D.S., Ye, M., Charlesworth, A., Hayar, A., Electrical coupling: novel mechanism for sleep-wake control (2007) Sleep, 30, pp. 1405-1414
• Urbano, F.J., Leznik, E., Llinás, R.R., Modafinil enhances thalamocortical activity by increasing neuronal electrotonic coupling (2007) Proceedings of the National Academy of Sciences of the USA, 104, pp. 12554-12559
• Zolkowska, D., Jain, R., Rothman, R.B., Partilla, J.S., Roth, B.L., Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil (2009) J Pharmacol Exp Ther, 329, pp. 738-746
• Fuxe, K., Janson, A.M., Rosén, L., Finnman, U.B., Tanganelli, S., Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis (1992) Exp Brain Res, 88, pp. 117-130
• Ueki, A., Rosén, L., Andbjer, B., Finnman, U.B., Altamimi, U., The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway (1993) Exp Brain Res, 93, pp. 259-270
• Jenner, P., Zeng, B.Y., Smith, L.A., Pearce, R.K., Tel, B., Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset (2000) Exp Brain Res, 133, pp. 178-188
• van Vliet, S.A., Blezer, E.L., Jongsma, M.J., Vanwersch, R.A., Olivier, B., Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy (2008) Brain Res, 1189, pp. 219-228
• Raineri, M., Peskin, V., Goitia, B., Taravini, I.R., Giorgeri, S., Attenuated methamphetamine induced neurotoxicity by modafinil administration in mice (2011) Synapse, 65, pp. 1087-1098
• Streit, W.J., An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4) (1990) J Histochem Cytochem, 38, pp. 1683-1686
• Streit, W.J., Kreutzberg, G.W., Lectin binding by resting and reactive microglia (1987) J Neurocytol, 16, pp. 249-260
• LaVoie, M.J., Card, J.P., Hastings, T.G., Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity (2004) Exp Neurol, 187, pp. 47-57
• Davidson, C., Gow, A.J., Lee, T.H., Ellinwood, E.H., Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment (2001) Brain Res Brain Res Rev, 36, pp. 1-22
• Chiang, C.S., Stalder, A., Samimi, A., Campbell, I.L., Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice (1994) Dev Neurosci, 16, pp. 212-221
• Pu, C., Vorhees, C.V., Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum (1993) Brain Res Dev Brain Res, 72, pp. 325-328
• Beauvais, G., Atwell, K., Jayanthi, S., Ladenheim, B., Cadet, J.L., Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways (2011) PLoS One, 6, pp. e28946
• Miller, D.B., O'Callaghan, J.P., Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse (1994) J Pharmacol Exp Ther, 270, pp. 752-760
• Sulzer, D., Sonders, M.S., Poulsen, N.W., Galli, A., Mechanisms of neurotransmitter release by amphetamines: a review (2005) Prog Neurobiol, 75, pp. 406-433
• Goodwin, J.S., Larson, G.A., Swant, J., Sen, N., Javitch, J.A., Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo (2009) J Biol Chem, 284, pp. 2978-2989
• Volz, T.J., Hanson, G.R., Fleckenstein, A.E., The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits (2007) J Neurochem, 101, pp. 883-888
• Schmitt, K.C., Reith, M.E., The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors (2011) PLoS One, 6, pp. e25790
• Loland, C.J., Mereu, M., Okunola, O.M., Cao, J., Prisinzano, T.E., R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse (2012) Biol Psychiatry, , In press
• Fumagalli, F., Gainetdinov, R.R., Valenzano, K.J., Caron, M.G., Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter (1998) J Neurosci, 18, pp. 4861-4869
• Sandoval, V., Riddle, E.L., Hanson, G.R., Fleckenstein, A.E., Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits (2003) J Pharmacol Exp Ther, 304, pp. 1181-1187
• Jayanthi, S., Deng, X., Noailles, P.A., Ladenheim, B., Cadet, J.L., Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades (2004) FASEB J, 18, pp. 238-251
• Xie, T., McCann, U.D., Kim, S., Yuan, J., Ricaurte, G.A., Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity (2000) J Neurosci, 20, pp. 7838-7845
• Callahan, B.T., Cord, B.J., Yuan, J., McCann, U.D., Ricaurte, G.A., Inhibitors of Na+/H+ and Na+/Ca2+ exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity (2001) J Neurochem, 77, pp. 1348-1362
• Cox, B., Lee, T.F., Do central dopamine receptors have a physiological role in thermoregulation? (1977) Br J Pharmacol, 61, pp. 83-86
• Brown, S.J., Gisolfi, C.V., Mora, F., Temperature regulation and dopaminergic systems in the brain: does the substantia nigra play a role? (1982) Brain Res, 234, pp. 275-286
• Volkow, N.D., Fowler, J.S., Logan, J., Alexoff, D., Zhu, W., Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications (2009) JAMA, 301, pp. 1148-1154
• Paxinos, G., Franklin, K.B.J., (2001) The Mouse Brain in Stereotaxic Coordinates, , Second Edition, Academic Press, San Diego
• Minzenberg, M.J., Carter, C.S., Modafinil: a review of neurochemical actions and effects on cognition (2008) Neuropsychopharmacology, 33, pp. 1477-1502
• de la Garza 2nd, R., Zorick, T., London, E.D., Newton, T.F., Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers (2010) Drug Alcohol Depend, 106, pp. 173-180
• McGaugh, J., Mancino, M.J., Feldman, Z., Chopra, M.P., Gentry, W.B., Open-label pilot study of modafinil for methamphetamine dependence (2009) J Clin Psychopharmacol, 29, pp. 488-491
• Holtz, N.A., Lozama, A., Prisinzano, T.E., Carroll, M.E., Reinstatement of methamphetamine seeking in male and female rats treated with modafinil and allopregnanolone (2012) Drug Alcohol Depend, 120, pp. 233-237
• Reichel, C.M., See, R.E., Chronic modafinil effects on drug-seeking following methamphetamine self-administration in rats (2012) Int J Neuropsychopharmacol, 15, pp. 919-929

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------